ATE241375T1 - Verwendung eines serenoa repens extraktes zur herstellung eines arzneimittels zur behandlung von krebserkrankungen der prostata - Google Patents

Verwendung eines serenoa repens extraktes zur herstellung eines arzneimittels zur behandlung von krebserkrankungen der prostata

Info

Publication number
ATE241375T1
ATE241375T1 AT00915254T AT00915254T ATE241375T1 AT E241375 T1 ATE241375 T1 AT E241375T1 AT 00915254 T AT00915254 T AT 00915254T AT 00915254 T AT00915254 T AT 00915254T AT E241375 T1 ATE241375 T1 AT E241375T1
Authority
AT
Austria
Prior art keywords
production
prostate
treatment
serenoa repens
medicinal product
Prior art date
Application number
AT00915254T
Other languages
English (en)
Inventor
Pierre Fabre
Jean-Pierre Raynaud
Henri Cousse
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of ATE241375T1 publication Critical patent/ATE241375T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT00915254T 1999-03-30 2000-03-30 Verwendung eines serenoa repens extraktes zur herstellung eines arzneimittels zur behandlung von krebserkrankungen der prostata ATE241375T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9903959A FR2791573B1 (fr) 1999-03-30 1999-03-30 Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate
PCT/FR2000/000804 WO2000057892A1 (fr) 1999-03-30 2000-03-30 Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate

Publications (1)

Publication Number Publication Date
ATE241375T1 true ATE241375T1 (de) 2003-06-15

Family

ID=9543805

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00915254T ATE241375T1 (de) 1999-03-30 2000-03-30 Verwendung eines serenoa repens extraktes zur herstellung eines arzneimittels zur behandlung von krebserkrankungen der prostata

Country Status (15)

Country Link
US (1) US6599540B1 (de)
EP (1) EP1165108B1 (de)
JP (1) JP2003504306A (de)
CN (1) CN1261142C (de)
AT (1) ATE241375T1 (de)
AU (1) AU774568B2 (de)
BR (1) BR0009445A (de)
CA (1) CA2370775C (de)
DE (1) DE60003010T2 (de)
DK (1) DK1165108T3 (de)
ES (1) ES2199802T3 (de)
FR (1) FR2791573B1 (de)
MX (1) MXPA01009879A (de)
PT (1) PT1165108E (de)
WO (1) WO2000057892A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003211877A1 (en) 2002-03-11 2003-09-22 Takeda Chemical Industries, Ltd. Remedies for sex hormone-dependent disease
NZ555335A (en) 2004-11-25 2010-10-29 Univ Melbourne Phosphopeptide stabilised amorphous calcium phosphate complexes produced under acidic conditions
JP2008524221A (ja) * 2004-12-17 2008-07-10 バイオノボ・インコーポレーテッド Ｅｐｉｍｅｄｉｕｍ属植物の抽出液を用いた方法
US7482029B2 (en) * 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
AR057353A1 (es) 2005-06-07 2007-11-28 Univ Melbourne Mineralizacion dental
AR057402A1 (es) 2005-06-24 2007-12-05 Univ Melbourne Complejos de fosfato de calcio estabilizados por fosfopeptidos o fosfoproteinas, proceso de obtencion y composiciones farmaceuticas
US7700136B2 (en) * 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer
EP2705826B1 (de) 2006-02-09 2019-09-11 The University of Melbourne Fluoridzusammensetzung und Verfahren zur dentalen Mineralisierung
US20090042818A1 (en) * 2007-06-22 2009-02-12 Bionovo, Inc. Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
US20080319051A1 (en) * 2007-06-22 2008-12-25 Bionovo, Inc. Liquiritigenin and derivatives as selective estrogen receptor beta agonists
WO2009021196A1 (en) * 2007-08-08 2009-02-12 Bionovo, Inc. Extracts of ligustrum lucidum and uses thereof
JP2010539086A (ja) * 2007-09-07 2010-12-16 バイオノボ・インコーポレーテッド マメ科ファミリーのクズのエストロゲン性抽出物およびその使用
WO2009033025A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of asparagus conchinchinensis (lour.) merr of the liliaceae family and uses thereof
JP2010539085A (ja) * 2007-09-07 2010-12-16 バイオノボ・インコーポレーテッド マメ科ファミリーのキバナオウギのエストロゲン性抽出物およびその使用
US9155770B2 (en) * 2007-09-07 2015-10-13 Bionovo, Inc. Estrogenic extracts of Scuttelaria barbata D. don of the labiatae family and uses thereof
CA2706330A1 (en) * 2007-11-19 2009-06-04 Bionovo, Inc. A process of making purified extract of scutellaria barbata d. don
US20090130118A1 (en) * 2007-11-19 2009-05-21 Bionovo, Inc. Scutellaria barbata extract and combinations for the treatment of cancer
EP2219659A4 (de) * 2007-11-19 2010-11-17 Bionovo Inc Verfahren zum nachweis und zur behandlung von krebs mit einem extrakt aus scuttelaria barbata
EP2222321A4 (de) * 2007-11-19 2013-02-13 Bionovo Inc Therapie gegen krebs mit einem extrakt von scutellaria barbata
DE102008012988A1 (de) 2008-03-07 2009-09-10 S.W. Patentverwertungs Ltd. Zusammensetzung und Verwendungen zur Beeinflussung des Haarwachstums
US20090258942A1 (en) * 2008-04-14 2009-10-15 Bionovo, Inc. Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
EP2310024A4 (de) * 2008-05-06 2012-07-25 Bionovo Inc Östrogene extrakte zur behandlung von vagina- und vulvaatrophie
EP2294402A2 (de) * 2008-06-05 2011-03-16 Bionovo Inc. Verfahren zur quantifizierung mehrerer bioaktiver stoffe aus botanischen zusammensetzungen
US20090312437A1 (en) * 2008-06-06 2009-12-17 Bionovo, Inc., A Delaware Corporation Anthraquinones and Analogs from Rhuem palmatum for Treatment of Estrogen Receptor Beta-Mediated Conditions
CN102112141B (zh) * 2008-07-31 2013-03-06 希格马托制药工业公司 用于预防前列腺癌或减缓前列腺癌发展的组合物
EP2340027A4 (de) * 2008-09-03 2012-04-04 Bionovo Inc Verfahren und zusammensetzungen zur behandlung von krebs
US20100303936A1 (en) * 2009-04-28 2010-12-02 Bionovo, Inc. A Delaware Corporation Method of reducing fat accumulation and inducing weight loss
FR2963561B1 (fr) * 2010-08-03 2013-04-12 Pf Medicament Composition pharmaceutique contenant un extrait de serenoa repens
US10441561B2 (en) 2012-07-26 2019-10-15 The William M. Yanbrough Foundation Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
MX378581B (es) 2013-07-23 2025-03-10 Univ Melbourne Composiciones y metodos para la mineralizacion dental.
ES2959412T3 (es) 2013-12-24 2024-02-26 Univ Melbourne Composiciones estañosas estabilizadas
CZ306733B6 (cs) * 2014-08-27 2017-05-31 Walmark, A.S. Doplněk stravy na bázi klikvy velkoplodé pro použití k oddálení biochemického návratu karcinomu prostaty
EA201991933A1 (ru) 2017-03-14 2020-03-05 Де Юниверсити Оф Мельбурн Лечение гингивита
EA201991935A1 (ru) 2017-03-14 2020-02-14 Де Юниверсити Оф Мельбурн Комплексы для лечения чувствительности
US12569417B2 (en) 2019-03-13 2026-03-10 The University Of Melbourne Compositions and methods for promoting mineralization

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2465486A1 (fr) * 1979-09-21 1981-03-27 Roussel Uclaf Nouvelle application utilisant la lh-rh ou des agonistes
FR2480754A1 (fr) * 1980-04-21 1981-10-23 Fabre Sa Pierre Procede d'obtention d'un extrait stable et desodorise de sabal serrulatum antiprostatique
IT1258305B (it) * 1992-04-10 1996-02-22 Zambeletti Spa L Composizioni farmaceutiche rettali per il trattamento dell'ipertrofia prostatica
US6039950A (en) * 1995-04-14 2000-03-21 University Of Southern California Pharmaceutical grade saw palmetto
US6107090A (en) * 1996-05-06 2000-08-22 Cornell Research Foundation, Inc. Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
US5665393A (en) * 1996-09-03 1997-09-09 International Medical Research, Inc. Herbal composition for treating prostate carcinoma
ES2297934T3 (es) * 1998-08-03 2008-05-01 Ronald E. Wheeler Formula prostatica.
US6482447B2 (en) * 1999-09-10 2002-11-19 Glenn Braswell Method and composition for the treatment of benign prostate hypertrophy (BPH) and prevention of prostate cancer
US6261607B1 (en) * 1999-10-19 2001-07-17 Thomas Newmark Composition for promoting prostate health containing selenium and herbal extracts
US6200573B1 (en) * 1999-12-03 2001-03-13 Starcor Pharmaceuticals, Inc. Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia

Also Published As

Publication number Publication date
CA2370775C (fr) 2011-06-21
DK1165108T3 (da) 2003-09-22
AU3663100A (en) 2000-10-16
WO2000057892A1 (fr) 2000-10-05
EP1165108B1 (de) 2003-05-28
DE60003010T2 (de) 2004-04-01
FR2791573B1 (fr) 2003-04-11
PT1165108E (pt) 2003-10-31
DE60003010D1 (de) 2003-07-03
FR2791573A1 (fr) 2000-10-06
US6599540B1 (en) 2003-07-29
BR0009445A (pt) 2002-01-08
CA2370775A1 (fr) 2000-10-05
CN1261142C (zh) 2006-06-28
ES2199802T3 (es) 2004-03-01
JP2003504306A (ja) 2003-02-04
CN1346277A (zh) 2002-04-24
AU774568B2 (en) 2004-07-01
MXPA01009879A (es) 2002-05-06
EP1165108A1 (de) 2002-01-02

Similar Documents

Publication Publication Date Title
ATE241375T1 (de) Verwendung eines serenoa repens extraktes zur herstellung eines arzneimittels zur behandlung von krebserkrankungen der prostata
DE60023476D1 (de) Kombination von doctaxel und rhumab her2 zür krebsbehandlung
CZ2000531A3 (en) Method of prevention or therapy of estrogen-dependent diseases and disorders
BR9710686A (pt) Método de tratamento de tumores malignos com tiroxinas análogas não possuindo atividade hormonal siginificativa.
MXPA03003960A (es) Combinaciones de farmacos (v.gr., clorpromazina y pentamidina) para el tratamiento de desordenes neoplasticos.
DE60213386D1 (de) Geldanamycinderivate zur krebsbehandlung
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
ATE299022T1 (de) Verwendung von cyclopamine zur herstellung eines arzneimittels zur behandlung von psoriasis
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
WO2022271810A3 (en) Bicyclic peptidyl pan-ras inhibitors
WO2023164455A3 (en) Compositions and methods to modulate the immune system
DE602004016376D1 (de) Kombination von et-743 mit 5-fluorouracil pro-drugs zur behandlung von krebs
AU2020327022A8 (en) Method of treating cancer
DE60116075D1 (de) Behandlung von tumoren mit photodynamischer therapie
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
MXPA00010254A (es) Tratamiento de disfuncion sexual en ciertos grupos de pacientes.
DE60216292D1 (de) Calciumtrifluoracetat mit zytotoxischer wirkung
DE60002552D1 (de) Verwendung von einem bpi protein zur herstellung eines medikamentes zur behandlung von chronischen herzerkrankungen
RU94024337A (ru) Антиметастатическое средство
DE60037402D1 (de) Behandlung von autoimmunkrankheiten mit einem extrakt von amerikanischem ginseng
MXPA05013827A (es) Composiciones que comprenden zd6126 junto con 5-fu, cpt-11 o 5-fu y cpt-11, que tienen actividad de dano vascular, para tratar cancer colorectal e. g.
DE59009724D1 (de) Verwendung von 7-oh-1,2-benzopyron zur herstellung eines arzneimittels zur behandlung von malignen tumoren beim menschen.
ATE337783T1 (de) Neue therapeutische verwendung eines derivates von thienylcyclohexylamine zur behandlung von schmerzen
HK20025489A1 (en) Use of an extract from rabbit skin inflamed by vaccinia virus for treating cancer
DE59506911D1 (de) Verwendung von intravenös applizierbarem eisen zur therapie von tumorerkrankungen und/oder infektionskrankheiten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1165108

Country of ref document: EP